Compare MITK & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MITK | MRVI |
|---|---|---|
| Founded | 1983 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.4M | 449.6M |
| IPO Year | N/A | 2020 |
| Metric | MITK | MRVI |
|---|---|---|
| Price | $10.11 | $3.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $13.50 | $4.57 |
| AVG Volume (30 Days) | 595.0K | ★ 1.2M |
| Earning Date | 02-09-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.43 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $179,691,000.00 | ★ $192,435,000.00 |
| Revenue This Year | $8.41 | N/A |
| Revenue Next Year | $7.75 | $10.00 |
| P/E Ratio | $53.95 | ★ N/A |
| Revenue Growth | ★ 4.42 | N/A |
| 52 Week Low | $6.93 | $1.67 |
| 52 Week High | $11.39 | $6.05 |
| Indicator | MITK | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 51.71 |
| Support Level | $9.85 | $3.81 |
| Resistance Level | $10.74 | $4.11 |
| Average True Range (ATR) | 0.29 | 0.19 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 29.78 | 54.64 |
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.